APREMILAST ZENTIVA 10 mg, APREMILAST ZENTIVA 20 mg, film-coated tablet, APREMILAST ZENTIVA 30 mg, film-coated tablet 4 tablets
Active ingredients: Apremilast
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APREMILAST ZENTIVA 10 mg, APREMILAST ZENTIVA 20 mg, comprimé pelliculé, APREMILAST ZENTIVA 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquettes PVC-Aluminium de 1 comprimé de 10 mg - 4 plaquettes PVC-Aluminium de 1 comprimé de 20 mg - 19 plaquettes PVC-Aluminium de 1 comprimé de 30 mg. Pack d'initiation de traitement de 27 comprimés
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66842942CIP73030899CIP133400930308998Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉMILASTcomprimé 10 mg | 10 mg · un comprimé | SA |
| APRÉMILASTcomprimé 20 mg | 20 mg · un comprimé | SA |
| APRÉMILASTcomprimé 30 mg | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.